For adults with mild-to-moderate primary open-angle glaucoma who are planning to have
cataract surgery, technology has finally excelled to meet demand with the remarkable new iStent inject® implant.
The smallest implant known to medicine, the iStent inject® contains two tiny stents crafted to continually manage intraocular pressure and naturally relieve the eye of excess fluid. Lake Eye’s Dr. Scott Wehrly, Dr. Scot Holman and Dr. Vinay Gutti are the first local eye surgeons to perform this remarkable procedure. “As the first local practice to perform endoscopic cyclophotocoagulation, or ECP, with the iStent Trabecular Micro-Bypass, of course we were intrigued by the new iStent inject,” says Dr. Wehrly. “It takes the technology a step further, with two stents to control fluid and pressure, which for many patients means arresting the progression of glaucoma and protecting vision from further damage.”
“We are excited to be the first local eye surgeons to implant the iStent inject,” says Dr. Holman. “For glaucoma patients undergoing cataract surgery, this combined procedure is a way to
remove cataracts, improve vision with
a new, custom-selected lens, and manage glaucoma so effectively that some patients are able to reduce their need for glaucoma medication. It’s remarkable,” adds Dr. Gutti.
The iStent inject® stents are carefully placed during cataract surgery. Afterward, the patient will neither see nor feel the implant, yet it will work continuously to safely assist the eye’s fluid drainage system, help maintain healthy eye pressure, and prevent or reduce the progression of glaucoma-related vision loss. For some patients, it can mean a reduction of the number of glaucoma medications they need.
If you have mild-to-moderate primary open-angle glaucoma and are planning on having cataract surgery, talk to your Lake Eye doctor about the iStent inject® and open your eyes to a brighter, clearer future.
Lake Eye Associates